Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Heartseed, Inc. ( (JP:219A) ) has provided an announcement.
Heartseed Inc. announced a revision of its full-year financial forecast for the fiscal year ending December 31, 2025, due to lower-than-expected research and development expenses. The revised forecast indicates significant improvements in operating, ordinary, and net profits, suggesting a positive financial outlook for the company.
The most recent analyst rating on (JP:219A) stock is a Hold with a Yen1361.00 price target. To see the full list of analyst forecasts on Heartseed, Inc. stock, see the JP:219A Stock Forecast page.
More about Heartseed, Inc.
Heartseed Inc. operates in the biotechnology industry, focusing on the development of regenerative medicine products and therapies.
Average Trading Volume: 1,882,905
Technical Sentiment Signal: Sell
Current Market Cap: Yen50.73B
See more insights into 219A stock on TipRanks’ Stock Analysis page.